A Reactive Oxygen Species-Mediated, Self-Perpetuating Loop Persistently Activates Platelet-Derived Growth Factor Receptor α

REFERENCES

• Heinrich MC, Corless CL, Duensing A, McGreevey L, Chen CJ, Joseph N, Singer S, Griffith DJ, Haley A, Town A, Demetri GD, Fletcher CD, Fletcher JA. 2003. PDGFRA activating mutations in gastrointestinal stromal tumors. Science 299:708–710. http://dx.doi.org/10.1126/science.1079666.
   PubMed Web of Science ®Google Scholar
• Hirota S, Ohashi A, Nishida T, Isozaki K, Kinoshita K, Shinomura Y, Kitamura Y. 2003. Gain-of-function mutations of platelet-derived growth factor receptor alpha gene in gastrointestinal stromal tumors. Gastroenterology 125:660–667. http://dx.doi.org/10.1016/S0016-5085(03)01046-1.
   PubMed Web of Science ®Google Scholar
• Andrae J, Gallini R, Betsholtz C. 2008. Role of platelet-derived growth factors in physiology and medicine. Genes Dev. 22:1276–1312. http://dx.doi.org/10.1101/gad.1653708.
   PubMed Web of Science ®Google Scholar
• Baroni SS, Santillo M, Bevilacqua F, Luchetti M, Spadoni T, Mancini M, Fraticelli P, Sambo P, Funaro A, Kazlauskas A, Avvedimento EV, Gabrielli A. 2006. Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis. N. Engl. J. Med. 354:2667–2676. http://dx.doi.org/10.1056/NEJMoa052955.
   PubMed Web of Science ®Google Scholar
• Lei H, Velez G, Hovland P, Hirose T, Gilbertson D, Kazlauskas A. 2009. Growth factors outside the PDGF family drive experimental PVR. Invest. Ophthalmol. Vis. Sci. 50:3394–3403. http://dx.doi.org/10.1167/iovs.08-3042.
   PubMedGoogle Scholar
• Clempus RE, Griendling KK. 2006. Reactive oxygen species signaling in vascular smooth muscle cells. Cardiovasc. Res. 71:216–225. http://dx.doi.org/10.1016/j.cardiores.2006.02.033.
   PubMed Web of Science ®Google Scholar
• Lambeth JD. 2004. NOX enzymes and the biology of reactive oxygen. Nat. Rev. Immunol. 4:181–189. http://dx.doi.org/10.1038/nri1312.
   PubMed Web of Science ®Google Scholar
• Oakley FD, Abbott D, Li Q, Engelhardt JF. 2009. Signaling components of redox active endosomes: the redoxosomes. Antioxid. Redox Signal. 11:1313–1333. http://dx.doi.org/10.1089/ars.2008.2363.
   PubMed Web of Science ®Google Scholar
• Meng TC, Fukada T, Tonks NK. 2002. Reversible oxidation and inactivation of protein tyrosine phosphatases in vivo. Mol. Cell 9:387–399. http://dx.doi.org/10.1016/S1097-2765(02)00445-8.
   PubMed Web of Science ®Google Scholar
• Tonks NK. 2005. Redox redux: revisiting PTPs and the control of cell signaling. Cell 121:667–670. http://dx.doi.org/10.1016/j.cell.2005.05.016.
   PubMed Web of Science ®Google Scholar
• Rhee SG, Kang SW, Jeong W, Chang TS, Yang KS, Woo HA. 2005. Intracellular messenger function of hydrogen peroxide and its regulation by peroxiredoxins. Curr. Opin. Cell Biol. 17:183–189. http://dx.doi.org/10.1016/j.ceb.2005.02.004.
   PubMed Web of Science ®Google Scholar
• Choi MH, Lee IK, Kim GW, Kim BU, Han YH, Yu DY, Park HS, Kim KY, Lee JS, Choi C, Bae YS, Lee BI, Rhee SG, Kang SW. 2005. Regulation of PDGF signalling and vascular remodelling by peroxiredoxin II. Nature 435:347–353. http://dx.doi.org/10.1038/nature03587.
   PubMed Web of Science ®Google Scholar
• Lei H, Kazlauskas A. 2009. Growth factors outside of the platelet-derived growth factor (PDGF) family employ reactive oxygen species/Src family kinases to activate PDGF receptor alpha and thereby promote proliferation and survival of cells. J. Biol. Chem. 284:6329–6336. http://dx.doi.org/10.1074/jbc.M808426200.
   PubMedGoogle Scholar
• Giannoni E, Buricchi F, Raugei G, Ramponi G, Chiarugi P. 2005. Intracellular reactive oxygen species activate Src tyrosine kinase during cell adhesion and anchorage-dependent cell growth. Mol. Cell. Biol. 25:6391–6403. http://dx.doi.org/10.1128/MCB.25.15.6391-6403.2005.
   PubMed Web of Science ®Google Scholar
• Kemble DJ, Sun G. 2009. Direct and specific inactivation of protein tyrosine kinases in the Src and FGFR families by reversible cysteine oxidation. Proc. Natl. Acad. Sci. U. S. A. 106:5070–5075. http://dx.doi.org/10.1073/pnas.0806117106.
   PubMed Web of Science ®Google Scholar
• Yoo SK, Starnes TW, Deng Q, Huttenlocher A. 2011. Lyn is a redox sensor that mediates leukocyte wound attraction in vivo. Nature 480:109–112. http://dx.doi.org/10.1038/nature10632.
   PubMed Web of Science ®Google Scholar
• Lei H, Velez G, Kazlauskas A. 2011. Pathological signaling via platelet-derived growth factor receptor alpha involves chronic activation of Akt and suppression of p53. Mol. Cell. Biol. 31:1788–1799. http://dx.doi.org/10.1128/MCB.01321-10.
   PubMedGoogle Scholar
• Pennock S, Kazlauskas A. 2012. Vascular endothelial growth factor A competitively inhibits platelet-derived growth factor (PDGF)-dependent activation of PDGF receptor and subsequent signaling events and cellular responses. Mol. Cell. Biol. 32:1955–1966. http://dx.doi.org/10.1128/MCB.06668-11.
   PubMed Web of Science ®Google Scholar
• Bae YS, Sung JY, Kim OS, Kim YJ, Hur KC, Kazlauskas A, Rhee SG. 2000. Platelet-derived growth factor-induced H2O2 production requires the activation of phosphatidylinositol 3-kinase. J. Biol. Chem. 275:10527–10531. http://dx.doi.org/10.1074/jbc.275.14.10527.
   PubMed Web of Science ®Google Scholar
• Gottlieb RA, Carreira RS. 2010. Autophagy in health and disease. 5. Mitophagy as a way of life. Am. J. Physiol. Cell Physiol. 299:C203–C210. http://dx.doi.org/10.1152/ajpcell.00097.2010.
   PubMed Web of Science ®Google Scholar
• Kazlauskas A. 1994. Receptor tyrosine kinases and their targets. Curr. Opin. Genet. Dev. 4:5–14. http://dx.doi.org/10.1016/0959-437X(94)90085-X.
   PubMedGoogle Scholar
• Claesson-Welsh L. 1994. Platelet-derived growth factor receptor signals. J. Biol. Chem. 269:32023–32026.
   PubMed Web of Science ®Google Scholar
• Hooshmand-Rad R, Yokote K, Heldin CH, Claesson-Welsh L. 1998. PDGF alpha-receptor mediated cellular responses are not dependent on Src family kinases in endothelial cells. J. Cell Sci. 111:607–614.
   PubMed Web of Science ®Google Scholar
• Gelderloos JA, Rosenkranz S, Bazenet C, Kazlauskas A. 1998. A role for Src in signal relay by the platelet-derived growth factor alpha receptor. J. Biol. Chem. 273:5908–5915. http://dx.doi.org/10.1074/jbc.273.10.5908.
   PubMedGoogle Scholar
• Sicheri F, Kuriyan J. 1997. Structures of Src-family tyrosine kinases. Curr. Opin. Struct. Biol. 7:777–785. http://dx.doi.org/10.1016/S0959-440X(97)80146-7.
   PubMed Web of Science ®Google Scholar
• Blake RA, Broome MA, Liu X, Wu J, Gishizky M, Sun L, Courtneidge SA. 2000. SU6656, a selective src family kinase inhibitor, used to probe growth factor signaling. Mol. Cell. Biol. 20:9018–9027. http://dx.doi.org/10.1128/MCB.20.23.9018-9027.2000.
   PubMed Web of Science ®Google Scholar
• Bazenet C, Kazlauskas A. 1994. The PDGF receptor alpha subunit activates p21ras and triggers DNA synthesis without interacting with rasGAP. Oncogene 9:517–525.
   PubMed Web of Science ®Google Scholar
• Lei H, Rheaume MA, Velez G, Mukai S, Kazlauskas A. 2011. Expression of PDGFRalpha is a determinant of the PVR potential of ARPE19 cells. Invest. Ophthalmol. Vis. Sci. 52:5016–5021. http://dx.doi.org/10.1167/iovs.11-7442.
   PubMedGoogle Scholar
• Andrews A, Balciunaite E, Leong FL, Tallquist M, Soriano P, Refojo M, Kazlauskas A. 1999. Platelet-derived growth factor plays a key role in proliferative vitreoretinopathy. Invest. Ophthalmol. Vis. Sci. 40:2683–2689.
   PubMed Web of Science ®Google Scholar
• Ory DS, Neugeboren BA, Mulligan RC. 1996. A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes. Proc. Natl. Acad. Sci. U. S. A. 93:11400–11406. http://dx.doi.org/10.1073/pnas.93.21.11400.
   PubMed Web of Science ®Google Scholar
• Waypa GB, Marks JD, Guzy R, Mungai PT, Schriewer J, Dokic D, Schumacker PT. 2010. Hypoxia triggers subcellular compartmental redox signaling in vascular smooth muscle cells. Circ. Res. 106:526–535. http://dx.doi.org/10.1161/CIRCRESAHA.109.206334.
   PubMed Web of Science ®Google Scholar
• Lei H, Venkatakrishnan A, Yu S, Kazlauskas A. 2007. Protein kinase A-dependent translocation of Hsp90 alpha impairs endothelial nitric-oxide synthase activity in high glucose and diabetes. J. Biol. Chem. 282:9364–9371. http://dx.doi.org/10.1074/jbc.M608985200.
   PubMed Web of Science ®Google Scholar
• Jones SM, Kazlauskas A. 2001. Growth-factor-dependent mitogenesis requires two distinct phases of signalling. Nat. Cell Biol. 3:165–172. http://dx.doi.org/10.1038/35055073.
   PubMed Web of Science ®Google Scholar
• DeMali KA, Whiteford CC, Ulug ET, Kazlauskas A. 1997. PDGF-dependent cellular transformation requires either PLC gamma or PI3K. J. Biol. Chem. 272:9011–9018. http://dx.doi.org/10.1074/jbc.272.14.9011.
   PubMed Web of Science ®Google Scholar
• Kypta RM, Goldberg Y, Ulug ET, Courtneidge SA. 1990. Association between the PDGF receptor and members of the src family of tyrosine kinases. Cell 62:481–492. http://dx.doi.org/10.1016/0092-8674(90)90013-5.
   PubMed Web of Science ®Google Scholar
• Baxter RM, Secrist JP, Vaillancourt RR, Kazlauskas A. 1998. Full activation of the platelet-derived growth factor beta-receptor kinase involves multiple events. J. Biol. Chem. 273:17050–17055. http://dx.doi.org/10.1074/jbc.273.27.17050.
   PubMedGoogle Scholar
• Lei H, Hovland P, Velez G, Haran A, Gilbertson D, Hirose T, Kazlauskas A. 2007. A potential role for PDGF-C in experimental and clinical proliferative vitreoretinopathy. Invest. Ophthalmol. Vis. Sci. 48:2335–2342. http://dx.doi.org/10.1167/iovs.06-0965.
   PubMedGoogle Scholar
• Pennock S, Rheaume MA, Mukai S, Kazlauskas A. 2011. A novel strategy to develop therapeutic approaches to prevent proliferative vitreoretinopathy. Am. J. Pathol. 179:2931–2940. http://dx.doi.org/10.1016/j.ajpath.2011.08.043.
   PubMedGoogle Scholar
• Bazenet CE, Gelderloos JA, Kazlauskas A. 1996. Phosphorylation of tyrosine 720 in the platelet-derived growth factor alpha receptor is required for binding of Grb2 and SHP-2 but not for activation of Ras or cell proliferation. Mol. Cell. Biol. 16:6926–6936.
   PubMed Web of Science ®Google Scholar
• Songyang Z, Carraway KLI, Eck MJ, Harrison SC, Feldman RA, Mohammadi M, Schlessinger J, Hubbard SR, Smith DP, Eng C, Lorenzo MJ, Ponder BAJ, Mayer BJ, Cantley LC. 1995. Catalytic specificity of protein-tyrosine kinases is critical for selective signalling. Nature 373:536–539. http://dx.doi.org/10.1038/373536a0.
   PubMed Web of Science ®Google Scholar
• Songyang Z, Blechner S, Hoaglund N, Hoekstra MF, Piwnica-Worms H, Cantley LC. 1994. Use of an oriented peptide library to determine the optimal substrates of protein kinases. Curr. Biol. 4:973–982. http://dx.doi.org/10.1016/S0960-9822(00)00221-9.
   PubMed Web of Science ®Google Scholar
• Songyang Z, Shoelson SE, Chaudhuri M, Gish G, Pawson T, Haser WG, King F, Roberts T, Ratnofsky S, Lechleider RJ, Neel BJ, Birge RB, Fajardo J, Chou MM, Hanafusa H, Schaffhausen B, Cantley LC. 1993. SH2 domains recognize specific phosphopeptide sequences. Cell 72:767–778. http://dx.doi.org/10.1016/0092-8674(93)90404-E.
   PubMed Web of Science ®Google Scholar
• Hubbard SR. 2004. Juxtamembrane autoinhibition in receptor tyrosine kinases. Nat. Rev. Mol. Cell Biol. 5:464–471. http://dx.doi.org/10.1038/nrm1399.
   PubMed Web of Science ®Google Scholar
• Klinghoffer RA, Sachsenmaier C, Cooper JA, Soriano P. 1999. Src family kinases are required for integrin but not PDGFR signal transduction. EMBO J. 18:2459–2471. http://dx.doi.org/10.1093/emboj/18.9.2459.
   PubMed Web of Science ®Google Scholar
• Lei H, Rheaume MA, Kazlauskas A. 2010. Recent developments in our understanding of how platelet-derived growth factor (PDGF) and its receptors contribute to proliferative vitreoretinopathy. Exp. Eye Res. 90:376–381. http://dx.doi.org/10.1016/j.exer.2009.11.003.
   PubMed Web of Science ®Google Scholar
• Sorkin A, Goh LK. 2009. Endocytosis and intracellular trafficking of ErbBs. Exp. Cell Res. 315:683–696. http://dx.doi.org/10.1016/j.yexcr.2008.07.029.
   PubMed Web of Science ®Google Scholar
• Olson LE, Soriano P. 2009. Increased PDGFRalpha activation disrupts connective tissue development and drives systemic fibrosis. Dev. Cell 16:303–313. http://dx.doi.org/10.1016/j.devcel.2008.12.003.
   PubMedGoogle Scholar
• Rosenkranz S, Ikuno Y, Leong FL, Klinghoffer RA, Miyake S, Band H, Kazlauskas A. 2000. Src family kinases negatively regulate platelet-derived growth factor alpha receptor-dependent signaling and disease progression. J. Biol. Chem. 275:9620–9627. http://dx.doi.org/10.1074/jbc.275.13.9620.
   PubMed Web of Science ®Google Scholar
• Lee JH, Budanov AV, Park EJ, Birse R, Kim TE, Perkins GA, Ocorr K, Ellisman MH, Bodmer R, Bier E, Karin M. 2010. Sestrin as a feedback inhibitor of TOR that prevents age-related pathologies. Science 327:1223–1228. http://dx.doi.org/10.1126/science.1182228.
   PubMed Web of Science ®Google Scholar
• Guertin DA, Sabatini DM. 2005. An expanding role for mTOR in cancer. Trends Mol. Med. 11:353–361. http://dx.doi.org/10.1016/j.molmed.2005.06.007.
   PubMed Web of Science ®Google Scholar
• Lee J, Giordano S, Zhang J. 2012. Autophagy, mitochondria and oxidative stress: cross-talk and redox signalling. Biochem. J. 441:523–540. http://dx.doi.org/10.1042/BJ20111451.
   PubMed Web of Science ®Google Scholar
• Manning BD, Cantley LC. 2003. Rheb fills a GAP between TSC and TOR. Trends Biochem. Sci. 28:573–576. http://dx.doi.org/10.1016/j.tibs.2003.09.003.
   PubMed Web of Science ®Google Scholar
• Li ZY, Yang Y, Ming M, Liu B. 2011. Mitochondrial ROS generation for regulation of autophagic pathways in cancer. Biochem. Biophys. Res. Commun. 414:5–8. http://dx.doi.org/10.1016/j.bbrc.2011.09.046.
   PubMed Web of Science ®Google Scholar
• Kuma A, Hatano M, Matsui M, Yamamoto A, Nakaya H, Yoshimori T, Ohsumi Y, Tokuhisa T, Mizushima N. 2004. The role of autophagy during the early neonatal starvation period. Nature 432:1032–1036. http://dx.doi.org/10.1038/nature03029.
   PubMed Web of Science ®Google Scholar
• Salazar M, Carracedo A, Salanueva IJ, Hernandez-Tiedra S, Lorente M, Egia A, Vazquez P, Blazquez C, Torres S, Garcia S, Nowak J, Fimia GM, Piacentini M, Cecconi F, Pandolfi PP, Gonzalez-Feria L, Iovanna JL, Guzman M, Boya P, Velasco G. 2009. Cannabinoid action induces autophagy-mediated cell death through stimulation of ER stress in human glioma cells. J. Clin. Invest. 119:1359–1372. http://dx.doi.org/10.1172/JCI37948.
   PubMed Web of Science ®Google Scholar
• Sundaresan M, Yu ZX, Ferrans VJ, Sulciner DJ, Gutkind JS, Irani K, Goldschmidt-Clermont PJ, Finkel T. 1996. Regulation of reactive-oxygen-species generation in fibroblasts by Rac1. Biochem. J. 318(Part 2):379–382.
   PubMedGoogle Scholar
• Suh YA, Arnold RS, Lassegue B, Shi J, Xu X, Sorescu D, Chung AB, Griendling KK, Lambeth JD. 1999. Cell transformation by the superoxide-generating oxidase Mox1. Nature 401:79–82. http://dx.doi.org/10.1038/43459.
   PubMed Web of Science ®Google Scholar
• Lei H, Velez G, Cui J, Samad A, Maberley D, Matsubara J, Kazlauskas A. 2010. N-acetylcysteine suppresses retinal detachment in an experimental model of proliferative vitreoretinopathy. Am. J. Pathol. 177:132–140. http://dx.doi.org/10.2353/ajpath.2010.090604.
   PubMedGoogle Scholar
• Hardwick JS, Sefton BM. 1995. Activation of the Lck tyrosine protein kinase by hydrogen peroxide requires the phosphorylation of Tyr-394. Proc. Natl. Acad. Sci. U. S. A. 92:4527–4531. http://dx.doi.org/10.1073/pnas.92.10.4527.
   PubMed Web of Science ®Google Scholar
• Abe J, Takahashi M, Ishida M, Lee JD, Berk BC. 1997. c-Src is required for oxidative stress-mediated activation of big mitogen-activated protein kinase 1. J. Biol. Chem. 272:20389–20394. http://dx.doi.org/10.1074/jbc.272.33.20389.
   PubMed Web of Science ®Google Scholar
• Yoshizaki A, Yanaba K, Yoshizaki A, Iwata Y, Komura K, Ogawa F, Takenaka M, Shimizu K, Asano Y, Hasegawa M, Fujimoto M, Sato S. 2010. Treatment with rapamycin prevents fibrosis in tight-skin and bleomycin-induced mouse models of systemic sclerosis. Arthritis Rheum. 62:2476–2487. http://dx.doi.org/10.1002/art.27498.
   PubMed Web of Science ®Google Scholar
• Pontrelli P, Rossini M, Infante B, Stallone G, Schena A, Loverre A, Ursi M, Verrienti R, Maiorano A, Zaza G, Ranieri E, Gesualdo L, Ditonno P, Bettocchi C, Schena FP, Grandaliano G. 2008. Rapamycin inhibits PAI-1 expression and reduces interstitial fibrosis and glomerulosclerosis in chronic allograft nephropathy. Transplantation 85:125–134. http://dx.doi.org/10.1097/01.tp.0000296831.91303.9a.
   PubMedGoogle Scholar
• Rangan GK, Coombes JD. 2007. Renoprotective effects of sirolimus in non-immune initiated focal segmental glomerulosclerosis. Nephrol. Dial. Transplant. 22:2175–2182. http://dx.doi.org/10.1093/ndt/gfm191.
   PubMedGoogle Scholar
• DeBerardinis RJ, Lum JJ, Hatzivassiliou G, Thompson CB. 2008. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab. 7:11–20. http://dx.doi.org/10.1016/j.cmet.2007.10.002.
   PubMed Web of Science ®Google Scholar
• Vander Heiden MG, Cantley LC, Thompson CB. 2009. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324:1029–1033. http://dx.doi.org/10.1126/science.1160809.
   PubMed Web of Science ®Google Scholar
• Vousden KH. 2010. Alternative fuel–another role for p53 in the regulation of metabolism. Proc. Natl. Acad. Sci. U. S. A. 107:7117–7118. http://dx.doi.org/10.1073/pnas.1002656107.
   PubMedGoogle Scholar
• Pennock S, Kim D, Mukai S, Kuhnle M, Chun DW, Matsubara J, Cui J, Ma P, Maberley D, Samad A, Van Geest RJ, Oberstein SL, Schlingemann RO, Kazlauskas A. 2013. Ranibizumab is a potential prophylaxis for proliferative vitreoretinopathy, a nonangiogenic blinding disease. Am. J. Pathol. 182:1659–1670. http://dx.doi.org/10.1016/j.ajpath.2013.01.052.
   PubMedGoogle Scholar
• Brugarolas J, Kaelin WGJr. 2004. Dysregulation of HIF and VEGF is a unifying feature of the familial hamartoma syndromes. Cancer Cell 6:7–10. http://dx.doi.org/10.1016/j.ccr.2004.06.020.
   PubMed Web of Science ®Google Scholar
• Wang RC, Wei Y, An Z, Zou Z, Xiao G, Bhagat G, White M, Reichelt J, Levine B. 2012. Akt-mediated regulation of autophagy and tumorigenesis through Beclin 1 phosphorylation. Science 338:956–959. http://dx.doi.org/10.1126/science.1225967.
   PubMed Web of Science ®Google Scholar
• Ozawa T, Brennan CW, Wang L, Squatrito M, Sasayama T, Nakada M, Huse JT, Pedraza A, Utsuki S, Yasui Y, Tandon A, Fomchenko EI, Oka H, Levine RL, Fujii K, Ladanyi M, Holland EC. 2010. PDGFRA gene rearrangements are frequent genetic events in PDGFRA-amplified glioblastomas. Genes Dev. 24:2205–2218. http://dx.doi.org/10.1101/gad.1972310.
   PubMed Web of Science ®Google Scholar
• Feng H, Hu B, Liu KW, Li Y, Lu X, Cheng T, Yiin JJ, Lu S, Keezer S, Fenton T, Furnari FB, Hamilton RL, Vuori K, Sarkaria JN, Nagane M, Nishikawa R, Cavenee WK, Cheng SY. 2011. Activation of Rac1 by Src-dependent phosphorylation of Dock180(Y1811) mediates PDGFRalpha-stimulated glioma tumorigenesis in mice and humans. J. Clin. Invest. 121:4670–4684. http://dx.doi.org/10.1172/JCI58559.
   PubMed Web of Science ®Google Scholar
• Liu KW, Feng H, Bachoo R, Kazlauskas A, Smith EM, Symes K, Hamilton RL, Nagane M, Nishikawa R, Hu B, Cheng SY. 2011. SHP-2/PTPN11 mediates gliomagenesis driven by PDGFRA and INK4A/ARF aberrations in mice and humans. J. Clin. Invest. 121:905–917. http://dx.doi.org/10.1172/JCI43690.
   PubMedGoogle Scholar
• Levine AJ. 1997. p53, the cellular gatekeeper for growth and division. Cell 88:323–331. http://dx.doi.org/10.1016/S0092-8674(00)81871-1.
   PubMed Web of Science ®Google Scholar
• Rosenkranz S, DeMali KA, Gelderloos JA, Bazenet C, Kazlauskas A. 1999. Identification of the receptor-associated signaling enzymes that are required for platelet-derived growth factor-AA-dependent chemotaxis and DNA synthesis. J. Biol. Chem. 274:28335–28343. http://dx.doi.org/10.1074/jbc.274.40.28335.
   PubMed Web of Science ®Google Scholar